14538-56-8C1CNCCN1.O=P(O)(O)ONQQWFVUVBGSGQN-UHFFFAOYSA-NSee also: Piperazinium dihydrogen phosphate (annotation moved to).
14538-56-8、1951-97-9、8057-14-5Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P203, P233, P260, P261, P264, P264+P265, P271, P272, P273, P280, P284, P302+P352, P304+P340, P305+P351+P338, P318, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
H315: Causes skin irritation [Warning Skin corrosion/irritation]
Chemical: Piperazine, phosphate (1:1)
Chemical: Piperazine, phosphate
REACH registered substance: Piperazine, compound with phosphoric acid (EC: 217-775-8)
IMAP assessments - Piperazine salts: Human health tier II assessment
IMAP assessments - Piperazine salts: Human health tier II assessment
Skin Irrit. 2 (100%)
Eye irritation - category 2A
UsesPiperazine Phosphate Monohydrate is used as an anthelmintic agent in the treatment of parasitic worm infections. Piperazine (P479900) derivatives are known to have high antiserotonin potency, antimicrobial activity, and potential anticancer activity in humans.
Loading…
DTXSID70932581CHEMBL2219733